Identification of Parkinson's disease subtypes may help understand underlying disease mechanisms and provide personalized management. Although clustering methods have been previously used for subtyping, they have reported generic subtypes of limited relevance in real life practice because patients do not always fit into a single category. The aim of this study was to identify new subtypes assuming that patients could be grouped differently according to certain sets of related symptoms. To this purpose, a novel model-based multi-partition clustering method was applied on data from an international, multi-center, cross-sectional study of 402 Parkinson's disease patients. Both motor and non-motor symptoms were considered. As a result, eight se...
OBJECTIVES:To use a data-driven approach to determine the existence and natural history of subtypes ...
Objectives To use a data-driven approach to determine the existence and natural history of subtypes ...
The construct of non-motor symptoms (NMS) subtyping in Parkinson Disease (PD) is emerging as a line ...
Identification of Parkinson's disease subtypes may help understand underlying disease mechanisms and...
Parkinson's disease is now considered a complex, multi-peptide, central, and peripheral nervous syst...
Parkinson's disease is now considered a complex, multi-peptide, central, and peripheral nervous syst...
The clinical variability between patients with Parkinson's disease (PD) may point at the existence o...
The second most common progressive neurodegenerative disorder, Parkinson’s disease (PD), is characte...
The clinical heterogeneity of Parkinson's disease (PD) may point at the existence of subtypes. Becau...
ObjectiveWe wished to explore Parkinson's disease (PD) subtypes by clustering analysis based on the ...
Parkinson's disease (PD) is a complex neurodegenerative disorder with diverse clinical manifestation...
The clinical heterogeneity of Parkinson__s disease (PD) patients may reflect the existence of subtyp...
The variability in the clinical phenotype of Parkinson’s disease seems to suggest the existence of s...
Parkinson's disease (PD) is associated with diverse clinical manifestations including motor and non-...
Objectives To use a data-driven approach to determine the existence and natural history of subtypes ...
OBJECTIVES:To use a data-driven approach to determine the existence and natural history of subtypes ...
Objectives To use a data-driven approach to determine the existence and natural history of subtypes ...
The construct of non-motor symptoms (NMS) subtyping in Parkinson Disease (PD) is emerging as a line ...
Identification of Parkinson's disease subtypes may help understand underlying disease mechanisms and...
Parkinson's disease is now considered a complex, multi-peptide, central, and peripheral nervous syst...
Parkinson's disease is now considered a complex, multi-peptide, central, and peripheral nervous syst...
The clinical variability between patients with Parkinson's disease (PD) may point at the existence o...
The second most common progressive neurodegenerative disorder, Parkinson’s disease (PD), is characte...
The clinical heterogeneity of Parkinson's disease (PD) may point at the existence of subtypes. Becau...
ObjectiveWe wished to explore Parkinson's disease (PD) subtypes by clustering analysis based on the ...
Parkinson's disease (PD) is a complex neurodegenerative disorder with diverse clinical manifestation...
The clinical heterogeneity of Parkinson__s disease (PD) patients may reflect the existence of subtyp...
The variability in the clinical phenotype of Parkinson’s disease seems to suggest the existence of s...
Parkinson's disease (PD) is associated with diverse clinical manifestations including motor and non-...
Objectives To use a data-driven approach to determine the existence and natural history of subtypes ...
OBJECTIVES:To use a data-driven approach to determine the existence and natural history of subtypes ...
Objectives To use a data-driven approach to determine the existence and natural history of subtypes ...
The construct of non-motor symptoms (NMS) subtyping in Parkinson Disease (PD) is emerging as a line ...